Related Experiment Video

Updated: May 16, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Characteristics of seizure frequency among Malaysian children diagnosed with structural-metabolic epilepsy

Muhannad Rm Salih1, Mohd Baldi Bahari, Mohamed Azmi Ahmad Hassali

  • 1College of Pharmacy, Al-Rashed University, Baghdad, Iraq.

Journal of Neurosciences in Rural Practice
|November 29, 2012
PubMed

Insights

Certain pediatric epilepsy subgroups, including Malays, females, and those under 4 with developmental delays or focal seizures, show better seizure frequency reduction with antiepileptic drug therapy. Polytherapy was linked to higher seizure frequency.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Management
  • Clinical Outcomes Research

Background:

  • Seizure control is paramount in epilepsy management.
  • Identifying factors influencing seizure frequency is crucial for effective treatment.

Purpose of the Study:

  • To evaluate seizure frequency patterns in pediatric epilepsy patients.
  • To explore relationships between seizure frequency, demographics, clinical factors, and treatment outcomes.

Main Methods:

  • Retrospective cohort study at a Pediatric Neurology Clinic.
  • Data collected over 6 months from medical records using a standardized form.

Main Results:

  • No overall association between seizure frequency and demographics/clinical characteristics.
  • Significant seizure reduction observed in specific subgroups: Malays, females, <4 years, global developmental delay/intellectual disability, and focal seizures.
  • Polytherapy associated with higher seizure frequency and increased likelihood of supra-therapeutic antiepileptic drug doses compared to monotherapy.

Conclusions:

  • Specific pediatric epilepsy subgroups demonstrate greater responsiveness to antiepileptic drug therapy.
  • Subgroups showing better response include Malays, females, younger children (<4 years), those with global developmental delay/intellectual disability, and focal seizures.
Abstract

Keywords:
Pediatricsseizure frequencystructural–metabolic epilepsy

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Related Concept Videos

Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...